SCHEMBL2423013

SCHEMBL2423013

O=S(=O)(Nc1nc2ccccc2nc1OCc1ccc2ccccc2c1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
LMNA P02545 2/20 0.51
HSD17B10 Q99714 1/20 0.51
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
AR P10275 1/20 0.50
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
EDNRB P24530 1/20 0.44
EDNRA P25101 1/20 0.44
RXFP1 Q9HBX9 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SLC40A1 Q9NP59 2/20 0.42
MAPT P10636 2/20 0.42
GLA P06280 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
BCL2L1 Q07817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2421332 0.90 KMT2A (0.59) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL2421908 0.87 KDM4E (0.57) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL2428254 0.84 RXFP1 (0.55) KDM4ELMNAHSD17B10RXFP1SLC40A1
SCHEMBL2426819 0.83 MEN1 (0.56) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL2422289 0.82 MEN1 (0.55) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL2422198 0.78 MEN1 (0.47) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL2419196 0.78 EDNRA (0.46) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL2428946 0.77 CCR4 (0.54) RXFP1
SCHEMBL2422609 0.76 CCR4 (0.58)
SCHEMBL2419910 0.76 MEN1 (0.50) KDM4ELMNAHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374802-B1 KYNURENINE PRODUCTION INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2014-04-23 EP disclosed
US-8673908-B2 Kynurenine production inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-03-18 US disclosed
EP-2374802-A1 KYNURENINE PRODUCTION INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2011-10-12 EP disclosed
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYOWA KIRIN CO., LTD. (JP) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYNU, KMO, IDO1 KDM4E 755/4885LMNA 4183/4885HSD17B10 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.